25
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Loving-Kindness Meditation vs Cognitive Processing Therapy for Posttraumatic Stress Disorder Among Veterans : A Randomized Clinical Trial

      research-article
      , MD 1 , 2 , , , MSW 3 , , MSW 4 , , PhD 3 , 5
      JAMA Network Open
      American Medical Association

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          Question

          Is group loving-kindness meditation noninferior to group cognitive processing therapy for treatment of posttraumatic stress disorder (PTSD) among veterans?

          Findings

          In this randomized clinical trial, 184 veterans with PTSD were assigned to group loving-kindness meditation or group cognitive processing therapy; the differences in the decrease from baseline to 6-month follow-up for measures of PTSD and depression were very similar and within predefined margins considered not meaningfully different. Attendance was better for loving-kindness meditation.

          Meaning

          This study adds to the evidence indicating that interventions without a specific focus on trauma, including meditation-based interventions, can yield results similar to trauma-focused therapies.

          Abstract

          This randomized clinical trial assesses whether group loving-kindness meditation therapy yields a similar result to group cognitive processing therapy for the treatment of posttraumatic stress disorder among veterans treated at a VA medical center.

          Abstract

          Importance

          Additional options are needed for treatment of posttraumatic stress disorder (PTSD) among veterans.

          Objective

          To determine whether group loving-kindness meditation is noninferior to group cognitive processing therapy for treatment of PTSD.

          Design, Setting, and Participants

          This randomized clinical noninferiority trial assessed PTSD and depression at baseline, posttreatment, and 3- and 6-month follow-up. Veterans were recruited from September 24, 2014, to February 5, 2018, from a large Veternas Affairs medical center in Seattle, Washington. A total of 184 veteran volunteers who met Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) criteria for PTSD were randomized. Data collection was completed November 28, 2018, and data analyses were conducted from December 10, 2018, to November 5, 2019.

          Interventions

          Each intervention comprised 12 weekly 90-minute group sessions. Loving-kindness meditation (n = 91) involves silent repetition of phrases intended to elicit feelings of kindness for oneself and others. Cognitive processing therapy (n = 93) combines cognitive restructuring with emotional processing of trauma-related content.

          Main Outcomes and Measures

          Co–primary outcomes were change in PTSD and depression scores over 6-month follow-up, assessed by the Clinician-Administered PTSD Scale (CAPS-5; range, 0-80; higher is worse) and Patient-Reported Outcome Measurement Information System (PROMIS; reported as standardized T-score with mean [SD] of 50 [10] points; higher is worse) depression measures. Noninferiority margins were 5 points on the CAPS-5 and 4 points on the PROMIS depression measure.

          Results

          Among the 184 veterans (mean [SD] age, 57.1 [13.1] years; 153 men [83.2%]; 107 White participants [58.2%]) included in the study, 91 (49.5%) were randomized to the loving-kindness group, and 93 (50.5%) were randomized to the cognitive processing group. The mean (SD) baseline CAPS-5 score was 35.5 (11.8) and mean (SD) PROMIS depression score was 60.9 (7.9). A total of 121 veterans (66%) completed 6-month follow-up. At 6 months posttreatment, mean CAPS-5 scores were 28.02 (95% CI, 24.72-31.32) for cognitive processing therapy and 25.92 (95% CI, 22.62-29.23) for loving-kindness meditation (difference, 2.09; 95% CI, −2.59 to 6.78), and mean PROMIS depression scores were 61.22 (95% CI, 59.21-63.23) for cognitive processing therapy and 58.88 (95% CI, 56.86-60.91) for loving-kindness meditation (difference, 2.34; 95% CI, −0.52 to 5.19). In superiority analyses, there were no significant between-group differences in CAPS-5 scores, whereas for PROMIS depression scores, greater reductions were found for loving-kindness meditation vs cognitive processing therapy (for patients attending ≥6 visits, ≥4-point improvement was noted in 24 [39.3%] veterans receiving loving-kindness meditation vs 9 (18.0%) receiving cognitive processing therapy; P = .03).

          Conclusions and Relevance

          Among veterans with PTSD, loving-kindness meditation resulted in reductions in PTSD symptoms that were noninferior to group cognitive processing therapy. For both interventions, the magnitude of improvement in PTSD symptoms was modest. Change over time in depressive symptoms was greater for loving-kindness meditation than for cognitive processing therapy.

          Trial Registration

          Clinicaltrials.gov Identifier: NCT01962714

          Related collections

          Most cited references48

          • Record: found
          • Abstract: found
          • Article: not found

          Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care.

          The current combat operations in Iraq and Afghanistan have involved U.S. military personnel in major ground combat and hazardous security duty. Studies are needed to systematically assess the mental health of members of the armed services who have participated in these operations and to inform policy with regard to the optimal delivery of mental health care to returning veterans. We studied members of four U.S. combat infantry units (three Army units and one Marine Corps unit) using an anonymous survey that was administered to the subjects either before their deployment to Iraq (n=2530) or three to four months after their return from combat duty in Iraq or Afghanistan (n=3671). The outcomes included major depression, generalized anxiety, and post-traumatic stress disorder (PTSD), which were evaluated on the basis of standardized, self-administered screening instruments. Exposure to combat was significantly greater among those who were deployed to Iraq than among those deployed to Afghanistan. The percentage of study subjects whose responses met the screening criteria for major depression, generalized anxiety, or PTSD was significantly higher after duty in Iraq (15.6 to 17.1 percent) than after duty in Afghanistan (11.2 percent) or before deployment to Iraq (9.3 percent); the largest difference was in the rate of PTSD. Of those whose responses were positive for a mental disorder, only 23 to 40 percent sought mental health care. Those whose responses were positive for a mental disorder were twice as likely as those whose responses were negative to report concern about possible stigmatization and other barriers to seeking mental health care. This study provides an initial look at the mental health of members of the Army and the Marine Corps who were involved in combat operations in Iraq and Afghanistan. Our findings indicate that among the study groups there was a significant risk of mental health problems and that the subjects reported important barriers to receiving mental health services, particularly the perception of stigma among those most in need of such care. Copyright 2004 Massachusetts Medical Society
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): Development and Initial Psychometric Evaluation in Military Veterans.

            The Clinician-Administered PTSD Scale (CAPS) is an extensively validated and widely used structured diagnostic interview for posttraumatic stress disorder (PTSD). The CAPS was recently revised to correspond with PTSD criteria in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5; American Psychiatric Association, 2013). This article describes the development of the CAPS for DSM-5 (CAPS-5) and presents the results of an initial psychometric evaluation of CAPS-5 scores in 2 samples of military veterans (Ns = 165 and 207). CAPS-5 diagnosis demonstrated strong interrater reliability (к = .78 to 1.00, depending on the scoring rule) and test-retest reliability (к = .83), as well as strong correspondence with a diagnosis based on the CAPS for DSM-IV (CAPS-IV; к = .84 when optimally calibrated). CAPS-5 total severity score demonstrated high internal consistency (α = .88) and interrater reliability (ICC = .91) and good test-retest reliability (ICC = .78). It also demonstrated good convergent validity with total severity score on the CAPS-IV (r = .83) and PTSD Checklist for DSM-5 (r = .66) and good discriminant validity with measures of anxiety, depression, somatization, functional impairment, psychopathy, and alcohol abuse (rs = .02 to .54). Overall, these results indicate that the CAPS-5 is a psychometrically sound measure of DSM-5 PTSD diagnosis and symptom severity. Importantly, the CAPS-5 strongly corresponds with the CAPS-IV, which suggests that backward compatibility with the CAPS-IV was maintained and that the CAPS-5 provides continuity in evidence-based assessment of PTSD in the transition from DSM-IV to DSM-5 criteria. (PsycINFO Database Record
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              The development of a clinician-administered PTSD scale

                Bookmark

                Author and article information

                Journal
                JAMA Netw Open
                JAMA Netw Open
                JAMA Netw Open
                JAMA Network Open
                American Medical Association
                2574-3805
                16 April 2021
                April 2021
                16 April 2021
                : 4
                : 4
                : e216604
                Affiliations
                [1 ]VA Puget Sound Health Care System, Seattle, Washington
                [2 ]Division of Gastroenterology, Department of Medicine, University of Washington School of Medicine, Seattle
                [3 ]Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System, Seattle, Washington
                [4 ]VA Research and Development, VA Puget Sound Health Care System, Seattle, Washington
                [5 ]Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle
                Author notes
                Article Information
                Accepted for Publication: March 1, 2021.
                Published: April 16, 2021. doi:10.1001/jamanetworkopen.2021.6604
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Kearney DJ et al. JAMA Network Open.
                Corresponding Author: David J. Kearney, MD, VA Medical Center 111GI, 1660 S Columbian Way, Seattle, WA 98108 ( david.kearney@ 123456va.gov ).
                Author Contributions: Dr Kearney and Ms Malte had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: Kearney, Simpson.
                Acquisition, analysis, or interpretation of data: All authors.
                Drafting of the manuscript: Kearney, Storms, Simpson.
                Critical revision of the manuscript for important intellectual content: Kearney, Malte, Simpson.
                Statistical analysis: Kearney, Malte.
                Obtained funding: Kearney, Simpson.
                Administrative, technical, or material support: Kearney, Storms.
                Supervision: Kearney, Simpson.
                Conflict of Interest Disclosures: None reported.
                Funding/Support: This study was supported with resources from and the use of facilities at the VA Puget Sound Health Care System. This research was supported by VA grant 1I01CX000857 (Drs Kearney and Simpson).
                Role of the Funder/Sponsor: The funder was involved in the design of the trial through the peer review process and oversaw the design and conduct of the study through appointment of a data monitoring committee; data collection, management, and the analysis plan were also overseen by the data monitoring committee. The sponsor did not participate in data analysis or interpretation, the preparation, review, or approval of the manuscript, or decision to submit the manuscript for publication.
                Disclaimer: The contents do not represent the views of the US Department of Veterans Affairs or the US government.
                Data Sharing Statement: See Supplement 3.
                Additional Contributions: Carolyn McManus, PT, MA, and Jonas Batt, MA, LMHC, taught the loving-kindness meditation classes and received compensation for their roles in the study. Martha Hickey, MSW, LICSW, and Bethann Gurrad, MA, LMHC, independent therapists previously trained in cognitive processing therapy at VA Puget Sound, provided cognitive processing therapy and received compensation for their roles in the study. Carie Rodgers, PhD, ABPP, VA Center of Excellence for Stress and Mental Health, University of California at San Diego School of Medicine, provided clinical supervision of cognitive processing therapy therapists and evaluation of cognitive processing therapy treatment fidelity, for which she received no compensation. VA Puget Sound research coordinators Kimberly Moore, BA, Ashley Morris, BA, Nicole Bernardi, MS, Larry Swanson, BA, and Michelle Martinez, MPH, received compensation for their roles in the study. Larry Swanson also created the research database for the study and received compensation for his role. Volunteer research assistants Kaitlin Harding, PhD, Madeline Noland, PhD, Lisa Kothari, MA, and Margaret Reese, BA, performed fidelity coding and did not receive compensation for their roles in the study.
                Article
                zoi210216
                10.1001/jamanetworkopen.2021.6604
                8052593
                33861329
                050e9083-d251-4c23-b72b-919209ade8a5
                Copyright 2021 Kearney DJ et al. JAMA Network Open.

                This is an open access article distributed under the terms of the CC-BY License.

                History
                : 4 November 2020
                : 1 March 2021
                Categories
                Research
                Original Investigation
                Online Only
                Psychiatry

                Comments

                Comment on this article